Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance
Clinical trial NCT05470504 · RECRUITING
Trial details
- NCT number
- NCT05470504
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-23
- Primary completion
- 2028-01-30
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.